Jacqueline Wright - 01 Jun 2023 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
02 Jun 2023, 21:18:20 UTC
Prior SEC filing
16 May 2023
Next SEC filing
02 Dec 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Nina Ayer, Attorney in Fact

Key filing fact

Jacqueline Wright filed Form 4 for EXELIXIS, INC. (EXEL) on 02 Jun 2023.

Key facts

  • This page summarizes Jacqueline Wright's Form 4 filing for EXELIXIS, INC. (EXEL).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Jun 2023, 21:18.

Change

  • Previous filing in this sequence was filed on 16 May 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EXEL transaction

Common Stock

Award

Transaction value
$0
Shares
+20,718
Change %
+67%
Price
$0.000000
Shares after
51,756
Date
01 Jun 2023
Ownership
Direct
Footnotes
F1, F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock.

Footnote F2

The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 100% of the shares subject to the restricted stock unit award on June 1, 2024, subject to the Reporting Person's continuous service through that date.

Footnote F3

Includes 36,362 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .